Oberadilol
Oberadilol (CID-3047798) is a Phosphodiesterase III inhibitor, non-selective β-adrenergic receptor blocker, vasodilator and positive inotropic agent. Oberadilol reduces left ventricular end-diastolic volume. Oberadilol is used in research related to chronic congestive heart failure and SARS-CoV-2 infection.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 114856-44-9
- Fòrmula: C25H30ClN5O3
- Peso molecular:483.99
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Ver todos los productos específicos de isoformas Adrenergic Receptor
More
Actividad biológica
|
PDE Ⅲ |
β adrenergic receptor |
Oberadilol is a pyridazinone derivative with vasodilatory, β-adrenergic blocking, and type III phosphodiesterase inhibitory activities[1].
Oberadilol reduces left ventricular end-diastolic volume and tends to increase ejection fraction[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 114856-44-9
-
Peso molecular 483.99
-
Fòrmula C25H30ClN5O3
-
SMILES
N#CC1=CC=C(Cl)C=C1OCC(O)CNC(C)(C)CNC2=CC=C(C(C(C)C3)=NNC3=O)C=C2
-
Synonyms
CID-3047798
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Araki S, et al. Cardiac and hemodynamic effects of TZC-5665, a novel pyridazinone derivative, and its metabolite in humans and dogs. General pharmacology. 1997 Apr;28(4):545-53. [Content Brief]
[3]. Srivastava A, et al. Exploring nature's bounty: identification of Withania somnifera as a promising source of therapeutic agents against COVID-19 by virtual screening and in silico evaluation. J Biomol Struct Dyn. 2022 Mar;40(4):1858-1908. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Oberadilol Related Classifications
HY-19088 Related Classifications
Powered by Bioz
- Oberadilol
- 114856-44-9
- CID-3047798
- CID3047798
- CID 3047798
- Phosphodiesterase (PDE)
- Adrenergic Receptor
- SARS-CoV
- protease inhibitor
- enzyme inhibitor
- chronic congestive heart failure
- GPCR ligand
- COVID-19
- SARS-CoV main protease
- phosphodiesterase-III
- β-adrenergic receptor
- Lipinski's rule of five
- SARS-CoV-2 main protease
- Inhibitor
- inhibitor
- inhibit